CANNABIS CULTURE – At best, it’s a tragic blunder that cannabis is listed as a Schedule I drug. The DEA labels a Schedule I drug as having a high potential for abuse. When cannabis’s lack of actual physical dependency is compared to the likelihood of addiction posed by drugs such as OxyContin (Schedule II) andRead More
CANNABIS CULTURE – Using cannabis and cannabinoids to treat various conditions is seen as controversial when it comes to treating children.
CANNABIS CULTURE- Sure, we know cannabis has proven helpful in relieving symptoms associated with cancer, epilepsy and glaucoma. But did you know, more and more evidence has been recorded that cannabis is more than beneficial, we actually need it?
CANNABIS CULTURE- The fact is, no one can say what definite effect months or years of cannabis use has on the brain, as there just isn’t enough research out there to say for sure. Moreover, the human brain (or indeed any type of brain) is incredibly complex, and there are all sorts of stimuli thatRead More
CANNABIS CULTURE- While autism is not yet widely considered a condition for which medical marijuana can be prescribed, doctors have noted cannabis’ therapeutic benefits to relieve autism symptoms. That is why marijuana is now respected by legions of doctors and scientists who understand the positive impacts that marijuana has on the patients that they treat.
CANNABIS CULTURE- Here at CCHQ (Cannabis Culture Headquarters), we are always after the most in-depth, expert analysis to help you, our tribe, get all the facts. In this spirit, meet the newest columnist to harmonize in the Cannabis Culture chorus, Doctor Frank.
Insys Therapeutics, the Arizona-based pharmaceutical company that recently became the biggest financial supporter of the campaign against marijuana legalization in that state
At least two Maryland state universities are jumping at the chance to work with marijuana growers to research the medicinal application and cultivation of cannabis.
CANNABIS CULTURE – Nature recently devoted an entire issue to cannabis.